-
-
-
-
-
-
-
UnitedHealthcare to separately reimburse Pacira's EXPAREL drug
-
-
-
-
-
-
-
Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting
-
-
-
-
-
-
-
Pacira BioSciences reports study links EXPAREL to reduced opioid use
-
-
-
-
-
-
-
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees
-
-
-
-
-
-
-
Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting
-
-
-
-
-
-
-
Pacira BioSciences adds Samit Hirawat to board of directors
-
-
-
-
-
-
-
Pacira BioSciences reports favorable outcomes for iovera device in back pain study
-
102,140 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

